Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.790
+0.060 (3.47%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $55.44 million as of April 25, 2025.
Market Cap
55.44M
Enterprise Value
-12.52M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $55.44M, a decrease of -84.43%. That is a compound annual growth rate of -83.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 55.40M | -35.51% |
| Dec 31, 2024 | 85.90M | -75.88% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.12B |
| UnitedHealth Group | 388.83B |
| Johnson & Johnson | 380.15B |
| AbbVie | 307.25B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.46B |
| AstraZeneca | 210.34B |
| Novartis AG | 209.93B |